213 related articles for article (PubMed ID: 27468652)
1. BRET-based β-arrestin2 recruitment to the histamine H1 receptor for investigating antihistamine binding kinetics.
Bosma R; Moritani R; Leurs R; Vischer HF
Pharmacol Res; 2016 Sep; 111():679-687. PubMed ID: 27468652
[TBL] [Abstract][Full Text] [Related]
2. Brain histamine H1 receptor occupancy measured by PET after oral administration of levocetirizine, a non-sedating antihistamine.
Hiraoka K; Tashiro M; Grobosch T; Maurer M; Oda K; Toyohara J; Ishii K; Ishiwata K; Yanai K
Expert Opin Drug Saf; 2015 Feb; 14(2):199-206. PubMed ID: 25466429
[TBL] [Abstract][Full Text] [Related]
3. Label-free versus conventional cellular assays: Functional investigations on the human histamine H
Lieb S; Littmann T; Plank N; Felixberger J; Tanaka M; Schäfer T; Krief S; Elz S; Friedland K; Bernhardt G; Wegener J; Ozawa T; Buschauer A
Pharmacol Res; 2016 Dec; 114():13-26. PubMed ID: 27751876
[TBL] [Abstract][Full Text] [Related]
4. NanoLuc-Based Methods to Measure β-Arrestin2 Recruitment to G Protein-Coupled Receptors.
Ma X; Leurs R; Vischer HF
Methods Mol Biol; 2021; 2268():233-248. PubMed ID: 34085273
[TBL] [Abstract][Full Text] [Related]
5. Constitutive activity of the histamine H(1) receptor reveals inverse agonism of histamine H(1) receptor antagonists.
Bakker RA; Wieland K; Timmerman H; Leurs R
Eur J Pharmacol; 2000 Jan; 387(1):R5-7. PubMed ID: 10633171
[TBL] [Abstract][Full Text] [Related]
6. Route to Prolonged Residence Time at the Histamine H
Bosma R; Wang Z; Kooistra AJ; Bushby N; Kuhne S; van den Bor J; Waring MJ; de Graaf C; de Esch IJ; Vischer HF; Sheppard RJ; Wijtmans M; Leurs R
J Med Chem; 2019 Jul; 62(14):6630-6644. PubMed ID: 31274307
[TBL] [Abstract][Full Text] [Related]
7. BRET-Based Biosensors to Measure Agonist Efficacies in Histamine H
Verweij EWE; Bosma R; Gao M; van den Bor J; Al Araaj B; de Munnik SM; Ma X; Leurs R; Vischer HF
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328605
[TBL] [Abstract][Full Text] [Related]
8. Vasopeptidase-activated latent ligands of the histamine receptor-1.
Gera L; Roy C; Charest-Morin X; Marceau F
Int Immunopharmacol; 2013 Nov; 17(3):677-83. PubMed ID: 24016859
[TBL] [Abstract][Full Text] [Related]
9. Desloratadine inhibits constitutive and histamine-stimulated nuclear factor-kappaB activity consistent with inverse agonism at the histamine H1 Receptor.
Wu RL; Anthes JC; Kreutner W; Harris AG; West RE
Int Arch Allergy Immunol; 2004 Dec; 135(4):313-8. PubMed ID: 15564772
[TBL] [Abstract][Full Text] [Related]
10. Histamine H1 receptor antagonism by cetirizine in isolated guinea pig tissues: influence of receptor reserve and dissociation kinetics.
Christophe B; Carlier B; Gillard M; Chatelain P; Peck M; Massingham R
Eur J Pharmacol; 2003 May; 470(1-2):87-94. PubMed ID: 12787835
[TBL] [Abstract][Full Text] [Related]
11. Effects of Rupatadine on Platelet- Activating Factor-Induced Human Mast Cell Degranulation Compared With Desloratadine and Levocetirizine (The MASPAF Study).
Munoz-Cano R; Ainsua-Enrich E; Torres-Atencio I; Martin M; Sánchez-Lopez J; Bartra J; Picado C; Mullol J; Valero A
J Investig Allergol Clin Immunol; 2017; 27(3):161-168. PubMed ID: 27758758
[TBL] [Abstract][Full Text] [Related]
12. Brain histamine H
Nakamura T; Hiraoka K; Harada R; Matsuzawa T; Ishikawa Y; Funaki Y; Yoshikawa T; Tashiro M; Yanai K; Okamura N
Pharmacol Res Perspect; 2019 Aug; 7(4):e00499. PubMed ID: 31338198
[TBL] [Abstract][Full Text] [Related]
13. Intact cell binding for in vitro prediction of sedative and non-sedative histamine H1-receptor antagonists based on receptor internalization.
Hishinuma S; Sato Y; Kobayashi Y; Komazaki H; Saito M
J Pharmacol Sci; 2008 May; 107(1):66-79. PubMed ID: 18446005
[TBL] [Abstract][Full Text] [Related]
14. Effects of impromidine- and arpromidine-derived guanidines on recombinant human and guinea pig histamine H1 and H2 receptors.
Xie SX; Schalkhausser F; Ye QZ; Seifert R; Buschauer A
Arch Pharm (Weinheim); 2007 Jan; 340(1):9-16. PubMed ID: 17206612
[TBL] [Abstract][Full Text] [Related]
15. Differential Regulation of Thermodynamic Binding Forces of Levocetirizine and (
Hishinuma S; Tamura Y; Kobayashi C; Akatsu C; Shoji M
Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30558340
[TBL] [Abstract][Full Text] [Related]
16. Histamine H1 receptor occupancy and pharmacodynamics of second generation H1-antihistamines.
Gillard M; Benedetti MS; Chatelain P; Baltes E
Inflamm Res; 2005 Sep; 54(9):367-9. PubMed ID: 16273334
[TBL] [Abstract][Full Text] [Related]
17. Biochemical characterization of desloratadine, a potent antagonist of the human histamine H(1) receptor.
Anthes JC; Gilchrest H; Richard C; Eckel S; Hesk D; West RE; Williams SM; Greenfeder S; Billah M; Kreutner W; Egan RE
Eur J Pharmacol; 2002 Aug; 449(3):229-37. PubMed ID: 12167464
[TBL] [Abstract][Full Text] [Related]
18. Histamine H4 and H1 receptors contribute to postinflammatory visceral hypersensitivity.
Deiteren A; De Man JG; Ruyssers NE; Moreels TG; Pelckmans PA; De Winter BY
Gut; 2014 Dec; 63(12):1873-82. PubMed ID: 24561612
[TBL] [Abstract][Full Text] [Related]
19. Probe dependency in the determination of ligand binding kinetics at a prototypical G protein-coupled receptor.
Bosma R; Stoddart LA; Georgi V; Bouzo-Lorenzo M; Bushby N; Inkoom L; Waring MJ; Briddon SJ; Vischer HF; Sheppard RJ; Fernández-Montalván A; Hill SJ; Leurs R
Sci Rep; 2019 May; 9(1):7906. PubMed ID: 31133718
[TBL] [Abstract][Full Text] [Related]
20. A comparison of levocetirizine and desloratadine in the histamine-induced wheal and flare response in human skin in vivo.
Popov TA; Dumitrascu D; Bachvarova A; Bocsan C; Dimitrov V; Church MK
Inflamm Res; 2006 Jun; 55(6):241-4. PubMed ID: 16955243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
